This week's Fierce Biotech is brought to you by Nitto Avecia Pharma Services.

Outsmart Quality Challenges Before They Crush Your Pipeline

Hello E,

Let’s be real—drug development has changed. But has your approach to analytical testing and manufacturing kept up? From mRNA and CAR-T to sterile fill-finish and endotoxin testing, the pressure’s on to deliver faster, safer, more compliant therapies. And the old playbook? It's outdated. Download our new report where in just a few pages, you’ll get insider insights on:

• How advanced analytical tools are preventing downstream disasters
• Predictive analytics that spot problems before they happen
• Why next-gen therapies demand smarter QC and process design
• What ESG-focused quality looks like in 2025
• The fill-finish upgrade your ops team will thank you for

Don’t fall behind while the industry moves ahead. This is your blueprint for building smarter, safer, and more resilient pharma processes.